“We Are A Partner To Society.”

Fresenius Medical Care China President And Executive Vice President For Asia–Pacific Alan Chen Is On A Mission To Provide Top-Quality Renal Care With An Open Mind.

- Ashton Kobler

The fate of those with renal insufficiency significantly changed when the first successful dialysis treatment was performed in 1945. Kidney failure no longer meant certain death and the impact of this procedure has been immeasurable. Fresenius Medical Care (FME) is the world’s largest provider of products and services for individuals with renal diseases and has a robust network of 3,815 dialysis clinics. Since 1990, the company has been providing renal care in China – a country with more than 500,000 patients currently receiving dialysis, according to the Chinese Society of Nephrology. In recent years FME has significantly expanded its product base in China, the second-largest market in the world after the US.

After a successful career spanning more than 20 years at General Electric Healthcare, DePuy Synthes and, later, Johnson & Johnson, Alan Chen joined FME China as China President and Executive Vice President for Asia–Pacific in 2014. At the time, Alan saw room for improvement in the company, in terms of strategy and distribution. He seized the opportunity to develop, together with his management team, a growth strategy, which has become a long-term, three-pronged approach.

First, FME focuses on technology leadership. Introducing new care systems, technology, products and treatments in China is imperative for the company to lead the market. “We are a leading company in an innovative industry both globally and in China. We need to find new ways to lead and develop the local market,” Alan says. Second, the company is helping and supporting education with local medical associations to provide care for more patients.